Advertisement

Topics

Evotec to Acquire Aptuit, Expanding Leadership in External Innovation

15:13 EDT 30 Jul 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Acquisition grows business substantially, expanding position as leading player in integrated outsourced drug discovery and development solutions (External Innovation) Value chain extension through uni...

Other Sources for this Article

Evotec AG:
Gabriele Hansen, +49.(0)40.56081-255
VP Corporate Communications & Investor Relations
gabriele.hansen@evotec.com

NEXT ARTICLE

More From BioPortfolio on "Evotec to Acquire Aptuit, Expanding Leadership in External Innovation"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...